Exploring the effects of ZhenQiFuZheng granules on allergic rhinitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the therapeutic effects of ZhenQi FuZheng granules on allergic rhinitis by examining its impact on intestinal flora and metabolites. It aims to establish a specimen library and utilize cell and animal models alongside clinical cohort research to assess the granules' mechanism of action. The hypothesis is that these granules can alter metabolic omics related to nasal inflammatory factors, potentially reducing type 2 inflammation in patients with allergic rhinitis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (18-65 years).
* Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .

Exclusion Criteria:

* Patients who refused to accept specimen and questionnaire collection.
* Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.

Where it's running

• The First Affiliated Hospital with Nanjing Medical University
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Lei Cheng
• Email: chenglei@jsph.org.cn
• Phone: +8613776620807

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PollenVax for mugwort pollen allergy

  This Phase 2 study tests PollenVax, a quick-course subcutaneous immunotherapy, in adults with mugwort pollen–triggered allergic rhinitis.

  Recruiting Phase 2 Kazakh National Agrarian University · Almaty, Almaty · NCT07563439

• Evaluating air purifiers for improving allergic rhinitis symptoms

  This study is testing whether using a special air purifier can help adults with moderate to severe allergies feel better compared to using a fake air purifier.

  Recruiting Yonsei University · Seoul · NCT06890572

• Assessing the impact of airway allergic diseases on children's and parents' quality of life

  This study looks at how having asthma or allergies affects the quality of life for children and their parents, comparing those getting special treatment to those on regular care.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT06535087

• Using ganciclovir capsules to treat severe allergic rhinitis

  This study is testing if ganciclovir capsules can help people with severe allergic rhinitis feel better and improve their quality of life.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT06436534

• Biomarker screening for allergic rhinitis treatment evaluation using a microneedle patch

  This study tests a new skin patch treatment for people with allergic rhinitis from dust mites to see if it works better and is safer than traditional allergy treatments.

  Recruiting Yonsei University · Seoul · NCT05922176

• Evaluating a new treatment for allergies to certain trees and grasses

  This study is testing a new allergy treatment for people aged 12 to 65 who are sensitive to certain tree and grass pollens to see if it can help reduce their allergy symptoms.

  Recruiting at 9 sites Phase 3 Inmunotek S.L. · Valladolid, Castille and León and 26 other locations · NCT04898283

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.